Cargando…
A New Paradigm in the Relationship between Gut Microbiota and Breast Cancer: β-glucuronidase Enzyme Identified as Potential Therapeutic Target
Breast cancer (BC) is the most frequently occurring malignancy and the second cancer-specific cause of mortality in women in developed countries. Over 70% of the total number of BCs are hormone receptor-positive (HR+), and elevated levels of circulating estrogen (E) in the blood have been shown to b...
Autores principales: | Fernández-Murga, M. Leonor, Gil-Ortiz, Fernando, Serrano-García, Lucía, Llombart-Cussac, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535898/ https://www.ncbi.nlm.nih.gov/pubmed/37764894 http://dx.doi.org/10.3390/pathogens12091086 |
Ejemplares similares
-
Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
por: Honrubia-Peris, Beatriz, et al.
Publicado: (2021) -
Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure
por: Creekmore, Benjamin C., et al.
Publicado: (2019) -
The Activity of the Enzymes Sulphatase and β-Glucuronidase in the Urine, Serum and Bladder Tissue
por: Boyland, E., et al.
Publicado: (1955) -
Extracellular vesicles protect glucuronidase model enzymes during freeze-drying
por: Frank, Julia, et al.
Publicado: (2018) -
In-Silico Characterization of Estrogen Reactivating β-Glucuronidase Enzyme in GIT Associated Microbiota of Normal Human and Breast Cancer Patients
por: Muccee, Fatima, et al.
Publicado: (2022)